Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lioure

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|May 1, 1995
Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patientsE Racadot, N Milpied, P Bordigoni, et al.
Revue De Pneumologie Clinique|January 1, 1989
[Pseudotumoral pneumocystosis: one case and a review of the literature]B Lioure, P Dufour, J M Lang, et al.
Transplantation|September 1, 1991
Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatmentP Tiberghien, E Racadot, B Lioure, et al.
Bone Marrow Transplantation|November 2, 2004
First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working PartyG Rosti, U De Giorgi, H Wandt, et al.
Transplantation|November 15, 1995
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III studyJ Y Cahn, P Bordigoni, P Tiberghien, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 22, 2010
[Occurrence of severe, persistent thrombocytopenia following allogeneic bone marrow transplantation, attributable to anti-HPA-1 allo-immunisation of the host]A Parissiadis, K Bilger, A Laplace, et al.
Bone Marrow Transplantation|March 23, 2011
Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMTP Bories, E Zink, J F Mattern, et al.
Annals of Hematology|May 6, 2004
Priming with GM-CSF for acute myelogenous leukemia (AML): GOELAM dataF Witz, J L Harousseau, F Guilhot, et al.
British Journal of Haematology|November 5, 1997
Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow TransplantationP Guardiola, H Esperou, D Cazals-Hatem, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
High dose chemotherapy in ovarian cancerE Pujade-Lauraine, H Curé, C Battista, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|May 1, 1995
Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patientsE Racadot, N Milpied, P Bordigoni, et al.
Revue De Pneumologie Clinique|January 1, 1989
[Pseudotumoral pneumocystosis: one case and a review of the literature]B Lioure, P Dufour, J M Lang, et al.
Transplantation|September 1, 1991
Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatmentP Tiberghien, E Racadot, B Lioure, et al.
Bone Marrow Transplantation|November 2, 2004
First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working PartyG Rosti, U De Giorgi, H Wandt, et al.
Transplantation|November 15, 1995
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III studyJ Y Cahn, P Bordigoni, P Tiberghien, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 22, 2010
[Occurrence of severe, persistent thrombocytopenia following allogeneic bone marrow transplantation, attributable to anti-HPA-1 allo-immunisation of the host]A Parissiadis, K Bilger, A Laplace, et al.
Bone Marrow Transplantation|March 23, 2011
Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMTP Bories, E Zink, J F Mattern, et al.
Annals of Hematology|May 6, 2004
Priming with GM-CSF for acute myelogenous leukemia (AML): GOELAM dataF Witz, J L Harousseau, F Guilhot, et al.
British Journal of Haematology|November 5, 1997
Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow TransplantationP Guardiola, H Esperou, D Cazals-Hatem, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
High dose chemotherapy in ovarian cancerE Pujade-Lauraine, H Curé, C Battista, et al.
Pageof 8